Filing Details

Accession Number:
0001209191-23-058943
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-12-18 16:01:57
Reporting Period:
2023-12-14
Accepted Time:
2023-12-18 16:01:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1649094 Vaxcyte Inc. PCVX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1230724 Andrew Guggenhime C/O Vaxcyte, Inc.
825 Industrial Road, Ste. 300
San Carlos CA 94070
President And Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-12-14 14,000 $5.35 93,474 No 4 M Direct
Common Stock Disposition 2023-12-14 14,000 $60.22 79,474 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2023-12-14 14,000 $0.00 14,000 $5.35
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
400,827 2030-05-11 No 4 M Direct
Footnotes
  1. The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted June 30, 2023.
  2. 1/4 of the shares subject to the option vested on May 1, 2021, and 1/48 of the shares vest monthly thereafter.